Interleukin-28 and hepatitis C virus genotype-4: Treatment-induced clearance and liver fibrosis

doi:10.3748/wjg.v18.i47.7003

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3256)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

370

HTML

2568

Figures (1-1)

152

Tables (1-2)

166

Sum=3256

Dec 21, 2012 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2012; 18(47): 7003-7008
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.7003

Open in New Tab Full Size Figure Download Figure

Figure 1 Genotype frequency in percentage of rs12979860 of the interleukin-28B gene under treatment with and without end of treatment response and with and without sustained virological response in chronic hepatitis C-genotype 4 patients. ETR: End of treatment response; SVR: Sustained viral response.

Citation: Derbala M, Rizk N, Shebl F, Alkaabi S, Eldweik N, John A, Sharma M, Yaqoob R, Almohanadi M, Butt M, Alejji K. Interleukin-28 and hepatitis C virus genotype-4: Treatment-induced clearance and liver fibrosis. World J Gastroenterol 2012; 18(47): 7003-7008
URL: https://www.wjgnet.com/1007-9327/full/v18/i47/7003.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i47.7003